Results 81 to 90 of about 5,613,091 (316)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Reasoned opinion on the modification of the existing MRL for folpet in wine grapes

open access: yesEFSA Journal, 2012
In accordance with Article 6 of Regulation (EC) No 396/2005, Austria, herewith referred as the evaluating Member State (EMS), received an application from Makhteshim Agan to modify the existing MRL for folpet in wine grapes.
European Food Safety Authority
doaj   +1 more source

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study [PDF]

open access: bronze, 2003
Michael Hedenus   +13 more
openalex   +1 more source

Pesticides, environment, and food safety

open access: yes, 2017
Agrochemicals have enabled to more than duplicate food production during the last century, and the current need to increase food production to feed a rapid growing human population maintains pressure on the intensive use of pesticides and fertilizers ...
F. Carvalho
semanticscholar   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Holding GLP-1 Agonists Prior to Elective Procedures

open access: yesPatient Safety, 2023
Patient Safety Authority
doaj   +1 more source

Reasoned opinion on the modification of the existing MRLs for ametoctradin in various commodities

open access: yesEFSA Journal, 2012
In accordance with Article 6 of Regulation (EC) No 396/2005, The Netherlands, hereafter referred to as the evaluating Member State (EMS), received an application from the company BASF SE to modify the existing MRL for the active substance ametoctradin in
European Food Safety Authority
doaj   +1 more source

Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children [PDF]

open access: bronze, 2012
Jeffrey S. Hyams   +13 more
openalex   +1 more source

Challenges in the Safety-Security Co-Assurance of Collaborative Industrial Robots [PDF]

open access: green, 2021
Mario Gleirscher   +5 more
openalex   +1 more source

Artificial intelligence, bias and clinical safety

open access: yesBMJ Quality & Safety, 2019
In medicine, artificial intelligence (AI) research is becoming increasingly focused on applying machine learning (ML) techniques to complex problems, and so allowing computers to make predictions from large amounts of patient data, by learning their own ...
R. Challen   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy